First-of-its-kind cancer vaccine helps reduce chances of melanoma patients’ tumors returning: study
Top Story
Archived
•
October 23, 2026
•
2 views
A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients’ tumors come back, according to results of a major study released Thursday by drugmakers Moderna and Merck.
Source: New York Post | https://nypost.com/feed/ - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



